| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 08/12/2004 | US20040156840 A preferred IgM is autoantigen IgM, in particular anti-ds-DNA and anti-phospholipid IgM; may be mixed with an antiinflammatory agent, an immunosuppressive agent and/or a cytostatic agent |
| 08/12/2004 | US20040156838 inducing cytotoxic T-lymphocytes that will specifically down-regulate B-cells producing autologous IgE, notably by means of nucleic acid vaccination or live vaccination; inducing a combined antibody and CTK response specific for IgE |
| 08/12/2004 | US20040156837 Haemophilus influenzae sialyltransferase and methods of use thereof |
| 08/12/2004 | US20040156832 vector for reverting cell lines to a pro-B cell-like state or to a germline-like state; generating immunoglobulins including immunoglobulin heavy and/or light chains and generating libraries of cells that produce arrays of immunoglobulins |
| 08/12/2004 | US20040156820 Adjuvant combination formulations |
| 08/12/2004 | DE10303664A1 Erkennungsmoleküle zur Behandlung und Detektion von Tumoren Recognition molecules for the treatment and detection of tumors |
| 08/12/2004 | CA2514877A1 Assay method for group transfer reactions |
| 08/12/2004 | CA2514653A1 Uses of integrin alphavbeta3 antagonists |
| 08/12/2004 | CA2514582A1 Amyloid-.beta.(1-42) oligomers, derivatives thereof, antibodies for the same, method for production and use thereof |
| 08/12/2004 | CA2514580A1 Compositions and methods of tolerizing a primate to an antigen |
| 08/12/2004 | CA2514419A1 Prostate cancer diagnosis and treatment |
| 08/12/2004 | CA2514226A1 Use of anti-cd100 antibodies |
| 08/12/2004 | CA2514177A1 Tolerance-induced targeted antibody production |
| 08/12/2004 | CA2514062A1 Compositions and methods for treating cancer using igsf9 and liv-1 |
| 08/12/2004 | CA2512174A1 Anti-integrin .alpha..nu..beta.3 antibody formulations and uses thereof |
| 08/12/2004 | CA2510267A1 Antibodies specific for plasmacytoid dendritic cells |
| 08/12/2004 | CA2509136A1 Human il-1 beta antagonists |
| 08/12/2004 | CA2508340A1 Transcriptional activator |
| 08/12/2004 | CA2485568A1 Variant integrin polypeptides and uses thereof |
| 08/11/2004 | EP1445615A1 Method for discrimination between infectious and noninfectious prions |
| 08/11/2004 | EP1445614A1 A method for the in vitro assessment of the progression status of an HIV virus in an invidual |
| 08/11/2004 | EP1445317A2 Compositions and methods for the diagnosis and treatment of tumor |
| 08/11/2004 | EP1445315A1 Human and mammalian stem cell-derived neuronal survival polypeptides |
| 08/11/2004 | EP1445264A1 Substance specific to pd-1 |
| 08/11/2004 | EP1444268A2 Bispecific anti-cd28 antibody molecule |
| 08/11/2004 | EP1444267A2 Affinity enhancement agents |
| 08/11/2004 | EP1444265A2 Compositions and methods for treating cellular response to injury and other proliferating cell disorders regulated by hyaladherin and hyaluronans |
| 08/11/2004 | EP1444262A2 Growth hormone variations in humans and their uses |
| 08/11/2004 | EP1444254A2 Molecules for disease detection and treatment |
| 08/11/2004 | EP1444250A1 Groel chimeric protein and vaccine |
| 08/11/2004 | EP1444245A2 Novel chromophores/fluorophores and methods for using the same |
| 08/11/2004 | EP1443965A1 Treatment of inflammatory conditions |
| 08/11/2004 | EP1443963A2 Antibody targeting compounds |
| 08/11/2004 | EP1443962A2 Method for the treatment of cardiotoxicity induced by antitumor compounds |
| 08/11/2004 | EP1443961A2 Glycoprotein compositions |
| 08/11/2004 | EP1443960A2 Antigen arrays presenting il-5, il-13 or eotaxin for treatment of allergic eosinophilic diseases |
| 08/11/2004 | EP1443957A2 Surface proteins from gram-positive bacteria having highly conserved motifs and antibodies that recognize them |
| 08/11/2004 | EP1443913A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 08/11/2004 | EP1242457B1 Intrabodies with defined framework that is stable in a reducing environment and applications thereof |
| 08/11/2004 | EP1051187B9 Treatment of follicular lymphomas using inhibitors of the lymphotoxin (lt) pathway |
| 08/11/2004 | EP0979410B1 Method for determining cytokine receptor activation by the use of an antibody |
| 08/11/2004 | EP0977859B1 The neurotrophic factor nnt-1 |
| 08/11/2004 | EP0927354B1 DIAGNOSTIC METHOD FOR DETECTION OF MOLECULAR FORMS OF EOSINOPHILIC CATIONIC PROTEIN (iso-ECPs) |
| 08/11/2004 | EP0894135B1 Multivalent and multispecific antigen-binding protein |
| 08/11/2004 | EP0862627B1 Neuropeptide y-y5 receptor |
| 08/11/2004 | EP0821728B1 Tie-2 ligands, methods of making and uses thereof |
| 08/11/2004 | EP0804453A4 Method for detection and treatment of breast cancer |
| 08/11/2004 | EP0642666B2 Hepatitis c assay |
| 08/11/2004 | EP0629132B1 Purified vacuolating toxin from helicobacter pylori and methods to use same |
| 08/11/2004 | EP0604560B1 Human cyclin e |
| 08/11/2004 | CN1520424A Immunoglobulins 2 |
| 08/11/2004 | CN1520423A Epitopes or mimotopes derived from C-eqsilon-3, or C-epsilon-4 domains of ige, antagonists thereof, and their thera peutic uses |
| 08/11/2004 | CN1520421A Recombinant tumor specific antibody and use thereof |
| 08/11/2004 | CN1519320A Polypeptide-human formamido pyrimidine-glycosylase 11.77 and polynucleotide for encoding polypoptide |
| 08/11/2004 | CN1519319A Polypeptide human RNA unwindase 9.25 and polynucleotide for encoding polypeptide |
| 08/11/2004 | CN1519318A Polypeptide human rudder chain dehydrogenase 9.46 and polynucleotide for encoding polypeptide |
| 08/11/2004 | CN1519317A Polypeptide-human oxidation enzyme 13.99 for hydrogen dioxide and polynucleotide for encoding polypeptide |
| 08/11/2004 | CN1519316A Polypeptide-human HADH dehydrogenase substructured protein I-9.25 and polynucleotide for encoding polypeptide |
| 08/11/2004 | CN1519315A Polypeptide human histidyl tRNA synzyme 13.09 and polynucleotide for encoding polypeptide |
| 08/11/2004 | CN1519257A Method for separating and purifying immunoglobulin for syndrome of serious acute respiratory tract of human |
| 08/11/2004 | CN1519256A Polypeptide-gonadotropic releasing homone 9.01 of human and polynucleotide for encoding polypeptide |
| 08/11/2004 | CN1519255A Polypeptide-DNA mismatching and modifying protein of human 12.98 and polynucleotide for encoding polypeptide |
| 08/11/2004 | CN1519254A Polypeptide-protein PWWP 9.24 related to malformation syndrome of human and polynucleotide for encoding polypeptide |
| 08/11/2004 | CN1519253A Polypeptide-EDF-1, endothelial cell differentiation factor 14.75 of human and polynucleotide for encoding polypeptide |
| 08/11/2004 | CN1519252A Polypeptide-conjugated protein 10.45 of human retina tumour and polynucleotide for encoding polypeptide |
| 08/11/2004 | CN1519251A Polypeptide-human zinc finger protein 9.45 and polynucleotide for encoding polypeptide |
| 08/11/2004 | CN1519250A Polypeptide-human ring finger protein 27.17 and polynucleotide for encoding polypeptide |
| 08/11/2004 | CN1519249A Polypeptide-polypeptide 13.93 for transporting anion in human tissue and polynucleotide for encoding polypeptide |
| 08/11/2004 | CN1519248A Polypeptide-human Big protein 11.77 and polynucleotide for encoding polypeptide |
| 08/11/2004 | CN1519247A Polypeptide-human vacuole protein 9, 46 and polynucleotide for encoding the polypeptide |
| 08/11/2004 | CN1161376C Major outer membrane protein CD of Moraxella |
| 08/11/2004 | CN1161152C Method and composition useful for inhibition of angiogenesis |
| 08/11/2004 | CN1161129C I(ex vivo) treatment of allogeneic and xanogeneic T-cells with gp39 antagonists |
| 08/10/2004 | US6774281 By transforming a plant with a polynucleotide sequence comprising a pathogen inducible promoter which regulates the expression of a plant signal transduction protein which when expressed gives rise to a hypersensitive response in plants |
| 08/10/2004 | US6774227 Reating disorders related to cellular overproliferation comprising neutralizing the production or activity of macrophage migration inhibitory factor (mif) |
| 08/10/2004 | US6774225 Antigenized antibody vaccine for foot-and-mouth disease |
| 08/10/2004 | US6774224 ULBP DNA and polypeptides |
| 08/10/2004 | US6774220 Compounds having lectinic properties and their biological applications |
| 08/10/2004 | US6774217 Use of fragile histidine triad gene (fhit) genes and their encoded proteins as diagnostic and therapeutic reagents for the detection and treatment of disease states associated with cell overproliferation |
| 08/10/2004 | US6774216 Antibody for use in diagnosis and treatment of immunological, inflammatory and nervous system disorders |
| 08/10/2004 | US6774214 Monocyte-derived homolog of FDF03 protein |
| 08/10/2004 | US6774117 MN gene and protein |
| 08/10/2004 | US6774107 Protein for blocking platelet adhesion |
| 08/10/2004 | US6773916 Administering sub-immunological sized antigen-binding molecule (fc/fv fragments) |
| 08/10/2004 | US6773908 From open reading frames; vaccines |
| 08/10/2004 | US6773897 Monitoring response of cells to antitumor agents; obbtain cells, recover nucleotide sequences, incubate with antitumor agent, monitor methylation of nucleotide sequences compare to control |
| 08/10/2004 | US6773891 Inducing the production of antibodies, in vivo, that specifically bind to nicotine. these conjugates comprise a nicotine hapten conjugated to an immunogenic carrier protein. the novel conjugates preserve the chirality of nicotine in |
| 08/10/2004 | US6773880 Bactericides; vaccine development; infection diagnosis; |
| 08/10/2004 | US6773710 Recombinant canine distemper virus vaccine against canine distemper and leishmaniasis |
| 08/10/2004 | US6773706 Enzymatic polypeptide for use in the diagnosis and treatment of bacterial infections |
| 08/10/2004 | US6773600 Use of a clathrate modifier, to promote passage of proteins during nanofiltration |
| 08/10/2004 | CA2457651A1 Antibodies for discrimination of prions |
| 08/10/2004 | CA2129101C Synthetic haemophilus influenzae conjugate vaccine |
| 08/10/2004 | CA2121041C Composite antibodies of human subgroup iv light chain capable of binding to tag-72 |
| 08/05/2004 | WO2004065936A2 Immunoglobulin e detection in mammalian species |
| 08/05/2004 | WO2004065611A1 Method of screening light chain of antibdoy |
| 08/05/2004 | WO2004065605A1 β1,3-N-ACETYL-D-GALACTOSAMINE TRANSFERASE PROTEIN, NUCLEIC ACID ENCODING THE SAME AND METHOD OF EXAMINING CANCERATION USING THE SAME |
| 08/05/2004 | WO2004065599A1 Lrp4/CORIN DOPAMINE-PRODUCING NEURON PROLIFERATION PRECURSOR CELL MARKER |
| 08/05/2004 | WO2004065590A2 Activation and expansion of t cells |
| 08/05/2004 | WO2004065569A2 Multi-functional antibodies |